{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:32:01Z","timestamp":1794411121257,"version":"4.9.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007927","name":"University of Oklahoma Health Sciences Center and Department of Veterans Affairs, Oklahoma City, Oklahoma, United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870121"],"award-info":[{"award-number":["31870121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.vaccine.2019.05.084","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T20:03:44Z","timestamp":1559765024000},"page":"3981-3988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["The advances in brucellosis vaccines"],"prefix":"10.1016","volume":"37","author":[{"given":"Huanhuan","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-6774","authenticated-orcid":false,"given":"Qisheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.084_b0005","doi-asserted-by":"crossref","first-page":"743509","DOI":"10.1155\/2013\/743509","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calderon","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2019.05.084_b0010","article-title":"Clinical manifestations of human brucellosis: a systematic review and meta-analysis","volume":"6","author":"Dean","year":"2012","journal-title":"PLoS NeglTrop Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.05.084_b0015","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ijantimicag.2010.06.013","article-title":"The changing Brucella ecology: novel reservoirs, new threats","volume":"36","author":"Pappas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2019.05.084_b0020","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/IAI.69.7.4528-4535.2001","article-title":"Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells","volume":"69","author":"Briones","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.vetmic.2009.06.021","article-title":"Brucellosis: a re-emerging zoonosis","volume":"140","author":"Seleem","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2310\/7060.2004.13551","article-title":"Brucellosis and international travel","volume":"11","author":"Memish","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.05.084_b0035","first-page":"147","article-title":"Vaccination against Brucella","volume":"13","author":"Nicoletti","year":"1990","journal-title":"Adv Biotechnol Process"},{"key":"10.1016\/j.vaccine.2019.05.084_b0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/iai.53.2.245-251.1986","article-title":"Comparison of living and nonliving vaccines for Brucella abortus in BALB\/c mice","volume":"53","author":"Montaraz","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1586\/14760584.4.6.915","article-title":"Essential role of vaccines in brucellosis control and eradication programs for livestock","volume":"4","author":"Olsen","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.084_b0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S1466252311000028","article-title":"A live vaccine from Brucella abortus strain 82 for control of cattle brucellosis in the Russian Federation","volume":"12","author":"Ivanov","year":"2011","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2019.05.084_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0378-1135(02)00235-3","article-title":"The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome","volume":"90","author":"Adams","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front Biol (Beijing)"},{"key":"10.1016\/j.vaccine.2019.05.084_b0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1135(02)00252-3","article-title":"Epidemiology and control of brucellosis in China","volume":"90","author":"Deqiu","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/vr.108.5.90","article-title":"Characterisation of Brucella abortus strain 19 cultures isolated from vaccinated cattle","volume":"108","author":"Thomas","year":"1981","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2019.05.084_b0080","doi-asserted-by":"crossref","first-page":"e2193","DOI":"10.1371\/journal.pone.0002193","article-title":"Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes","volume":"3","author":"Crasta","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.084_b0085","unstructured":"Manthei CA. Summary of controlled research with strain 191959."},{"key":"10.1016\/j.vaccine.2019.05.084_b0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vetmic.2008.05.003","article-title":"Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2","volume":"132","author":"Fiorentino","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0095","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1128\/IAI.66.11.5561-5564.1998","article-title":"Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice","volume":"66","author":"Tibor","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","article-title":"Development and trial of vaccines against Brucella","volume":"18","author":"Lalsiamthara","year":"2017","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2019.05.084_b0105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.01017-08","article-title":"The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle","volume":"77","author":"Arenas-Gamboa","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1469-0691.2008.02029.x","article-title":"Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina","volume":"14","author":"Wallach","year":"2008","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.vaccine.2019.05.084_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123374","article-title":"Brucella melitensis Biovar 1 and Brucella abortus S19 vaccine strain infections in milkers working at cattle farms in the Khartoum area, Sudan","volume":"10","author":"Osman","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2019.05.084_b0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/jb.73.2.211-217.1957","article-title":"Immunization against Brucella infection. VI. Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis","volume":"73","author":"Elberg","year":"1957","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0378-1135(02)00231-6","article-title":"Control of small ruminant brucellosis by use of Brucella melitensis Rev. 1 vaccine: laboratory aspects and field observations","volume":"90","author":"Banai","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0130","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.vaccine.2008.03.030","article-title":"Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams","volume":"26","author":"Munoz","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.20506\/rst.14.3.860","article-title":"Control of Brucella melitensis infection in a large camel herd in Saudi Arabia using antibiotherapy and vaccination with Rev. 1 vaccine","volume":"14","author":"Radwan","year":"1995","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2019.05.084_b0140","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JCM.00837-08","article-title":"Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains","volume":"46","author":"Lopez-Goni","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0145","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.40.2.1475-1480.2002","article-title":"Identification of the Brucella melitensis vaccine strain Rev. 1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene","volume":"40","author":"Bardenstein","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats","volume":"31","author":"Blasco","year":"1997","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2019.05.084_b0155","first-page":"354","article-title":"Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant. Level and duration of immunity in relation to dose of vaccine, recall injection and age of mice","volume":"59","author":"Bosseray","year":"1978","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0160","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/vr.112.20.476","article-title":"Serological response of cattle, sheep and goats in Kenya vaccinated with killed Brucella melitensis strain H38 adjuvant vaccine","volume":"112","author":"Waghela","year":"1983","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2019.05.084_b0165","article-title":"Study on the brucella melitensis strain M5-90 vaccine","author":"group R","year":"1991","journal-title":"Chinese J Control Endemic Disease"},{"key":"10.1016\/j.vaccine.2019.05.084_b0170","doi-asserted-by":"crossref","first-page":"e28485","DOI":"10.1371\/journal.pone.0028485","article-title":"Deep-sequencing analysis of the mouse transcriptome response to infection with Brucella melitensis strains of differing virulence","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.05.084_b0175","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1389201014666131226123016","article-title":"Research progress in live attenuated Brucella vaccine development","volume":"14","author":"Wang","year":"2013","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0180","doi-asserted-by":"crossref","first-page":"e70852","DOI":"10.1371\/journal.pone.0070852","article-title":"Comparative genomic analysis of Brucella melitensis vaccine strain M5 provides insights into virulence attenuation","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.05.084_b0185","article-title":"Comparative genomic analysis between newly sequenced Brucella suis Vaccine Strain S2 and the Virulent Brucella suis Strain 1330. Bmc","volume":"17","author":"Di","year":"2016","journal-title":"Genomics"},{"key":"10.1016\/j.vaccine.2019.05.084_b0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0264-410X(95)93135-V","article-title":"Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes","volume":"13","author":"Verger","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0264-410X(86)90131-3","article-title":"Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine","volume":"4","author":"Xin","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0200","first-page":"422","article-title":"Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya","volume":"24","author":"Mustafa","year":"1993","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0264-410X(93)90097-H","article-title":"Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams","volume":"11","author":"Blasco","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0264-410X(90)90247-J","article-title":"Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice","volume":"8","author":"Bosseray","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","article-title":"Biological properties of RB51; a stable rough strain of Brucella abortus","volume":"28","author":"Schurig","year":"1991","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0220","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/CDLI.6.5.760-764.1999","article-title":"Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains","volume":"6","author":"Vemulapalli","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0225","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2460\/ajvr.1996.57.08.1153","article-title":"Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis","volume":"57","author":"Cheville","year":"1996","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0230","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2460\/ajvr.1998.59.08.1016","article-title":"Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence","volume":"59","author":"Lord","year":"1998","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0235","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2004.02.041","article-title":"Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51","volume":"22","author":"Ashford","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0240","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2460\/ajvr.1997.58.05.472","article-title":"Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle","volume":"58","author":"Palmer","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0245","article-title":"study of the immunological properties and infectivity of brucella abortus strain 45\/20 mcewen in cattle","author":"Edwards","year":"1945","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2019.05.084_b0250","article-title":"The stability of the avirulent characters of Brucella abortus, strain 19 and strain 45\/20 in lactating and pregnant cows","author":"Taylor","year":"1949","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2019.05.084_b0255","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/vr.101.14.283","article-title":"The effect of immaturity of the calf on immunological responses to strain 19 and killed 45\/20 adjuvant vaccines","volume":"101","author":"Cunningham","year":"1977","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2019.05.084_b0265","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2460\/ajvr.1983.44.05.907","article-title":"Comparative efficacy of an experimental S45\/20 bacterin and a reduced dose of strain 19 vaccine against bovine brucellosis","volume":"44","author":"Woodard","year":"1983","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0270","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2460\/ajvr.1984.45.05.967","article-title":"Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex","volume":"45","author":"Schurig","year":"1984","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0275","article-title":"Experiments in contagious abortion. The immunity of cattle inoculated with vaccines of graded virulence","author":"Mcewen","year":"1940","journal-title":"Vet Rec"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.05.084_b0280","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1016\/j.vaccine.2010.03.050","article-title":"Comparative study of the immunobiological properties of live brucellosis vaccines","volume":"28","author":"Salmakov","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0285","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2460\/ajvr.1996.57.05.677","article-title":"Protection of BALB\/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4","volume":"57","author":"Winter","year":"1996","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0290","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.71.6.3261-3271.2003","article-title":"Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model","volume":"71","author":"Monreal","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0295","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.71.11.6264-6269.2003","article-title":"Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine","volume":"71","author":"Ugalde","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0300","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/IAI.72.8.4911-4917.2004","article-title":"Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB\/c mouse model","volume":"72","author":"Alcantara","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0305","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/IAI.69.10.6225-6230.2001","article-title":"Ferrochelatase is present in Brucella abortus and is critical for its intracellular survival and virulence","volume":"69","author":"Almiron","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0310","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1128\/IAI.72.9.5143-5149.2004","article-title":"Differential requirements for VirB1 and VirB2 during Brucella abortus infection","volume":"72","author":"den Hartigh","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0315","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1073\/pnas.0307137101","article-title":"Similarity to peroxisomal-membrane protein family reveals that Sinorhizobium and Brucella BacA affect lipid-A fatty acids","volume":"101","author":"Ferguson","year":"2004","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.05.084_b0320","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1126\/science.287.5462.2492","article-title":"Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival","volume":"287","author":"LeVier","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.084_b0325","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/IAI.01433-09","article-title":"The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice","volume":"78","author":"Trant","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0330","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","article-title":"Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0335","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/IAI.73.6.3294-3300.2005","article-title":"An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu, Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB\/c mice","volume":"73","author":"Onate","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetmic.2005.04.011","article-title":"Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7\/L12 protein","volume":"109","author":"Baloglu","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0345","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.vaccine.2018.02.069","article-title":"Safety implication of Salmonella based Brucella vaccine candidate in mice and in vitro human cell culture","volume":"36","author":"Lalsiamthara","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0350","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.vaccine.2015.04.004","article-title":"Intermediate rough Brucella abortus S19Deltaper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice","volume":"33","author":"Lalsiamthara","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0355","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.vaccine.2011.12.088","article-title":"Oral immunization of mice with recombinant Lactococcus lactis expressing Cu, Zn superoxide dismutase of Brucella abortus triggers protective immunity","volume":"30","author":"Saez","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(95)00047-E","article-title":"Selective humoral immune response of Balb\/C mice to Brucella abortus proteins expressed by vaccinia virus recombinants","volume":"45","author":"Toth","year":"1995","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0365","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1016\/j.vaccine.2014.08.073","article-title":"Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7\/L12 or Omp16 proteins: evaluation of protection in pregnant heifers","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0370","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetmic.2016.10.027","article-title":"Comparison of potential protection conferred by three immunization strategies (protein\/protein, DNA\/DNA, and DNA\/protein) against Brucella infection using Omp2b in BALB\/c Mice","volume":"197","author":"Golshani","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0380","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0264-410X(94)90035-3","article-title":"Modulation of immune responses in Balb\/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine","volume":"12","author":"Tabatabai","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0385","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1099\/0022-1317-49-2-165","article-title":"Identification and partial characterisation of a new protective antigen of Brucella abortus","volume":"49","author":"Cespedes","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0390","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0395","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0400","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0405","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnv003","article-title":"Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB\/c mice","volume":"362","author":"Hop","year":"2015","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2019.05.084_b0410","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0415","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.0902209","volume":"184","author":"Pasquevich","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0420","doi-asserted-by":"crossref","first-page":"e16203","DOI":"10.1371\/journal.pone.0016203","article-title":"An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice","volume":"6","author":"Pasquevich","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2019.05.084_b0425","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.69.10.6264-6270.2001","article-title":"Induction of immune response in BALB\/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0430","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0435","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.084_b0440","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1016\/j.vaccine.2012.09.039","article-title":"Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB\/c mice","volume":"30","author":"Sislema-Egas","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0445","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imbio.2005.09.004","article-title":"Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2","volume":"211","author":"Gonzalez-Smith","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2019.05.084_b0450","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.micinf.2008.05.007","article-title":"Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus","volume":"10","author":"Singha","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.05.084_b0455","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0952-7915(00)00118-7","article-title":"DNA vaccines: a key for inducing long-term cellular immunity","volume":"12","author":"Gurunathan","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0460","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erv.10.57","article-title":"DNA vaccines for targeting bacterial infections","volume":"9","author":"Ingolotti","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.084_b0465","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0378-1135(94)90034-5","article-title":"Immune responses to superoxide dismutase and synthetic peptides of superoxide dismutase in cattle vaccinated with Brucella abortus strain 19 or RB51","volume":"41","author":"Stevens","year":"1994","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0470","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-3659(02)00267-5","article-title":"Bacterial ghosts as vaccine candidates for veterinary applications","volume":"85","author":"Jalava","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.05.084_b0475","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.vetimm.2015.04.008","article-title":"Immune responses and protection induced by Brucella suis S2 bacterial ghosts in mice","volume":"166","author":"Liu","year":"2015","journal-title":"Vet Immunol Immunop"},{"key":"10.1016\/j.vaccine.2019.05.084_b0480","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0485","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.vaccine.2009.10.073","article-title":"Evaluation of particulate acellular vaccines against Brucella ovis infection in rams","volume":"28","author":"Da Costa","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0490","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2012.07.030","article-title":"Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles","volume":"162","author":"Da Costa","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.05.084_b0495","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","article-title":"PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: a promising alternate to traditional adjuvants","volume":"68","author":"Singh","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0500","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.vaccine.2019.02.005","article-title":"Induction of Th2-related immune responses and production of systemic IgA in mice intranasally immunized with Brucella abortus malate dehydrogenase loaded chitosan nanoparticles","volume":"37","author":"Soh","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0505","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2019.01.010","article-title":"A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31","volume":"207","author":"Abkar","year":"2019","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2019.05.084_b0510","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.084_b0515","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/20477724.2018.1446773","article-title":"Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design","volume":"112","author":"Kazi","year":"2018","journal-title":"Pathogens Glob Health"},{"key":"10.1016\/j.vaccine.2019.05.084_b0520","doi-asserted-by":"crossref","first-page":"e59751","DOI":"10.1371\/journal.pone.0059751","article-title":"Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approach","volume":"8","author":"Gomez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.05.084_b0525","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/omi.2015.0105","article-title":"Novel vaccine candidates against brucella melitensis identified through reverse vaccinology approach","volume":"19","author":"Vishnu","year":"2015","journal-title":"OMICS J Integrative Biol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0530","doi-asserted-by":"crossref","first-page":"1474517","DOI":"10.1155\/2018\/1474517","article-title":"Identification of cross-protective potential antigens against pathogenic Brucella spp. through combining pan-genome analysis with reverse vaccinology","volume":"2018","author":"Hisham","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0535","doi-asserted-by":"crossref","first-page":"297505","DOI":"10.1155\/2010\/297505","article-title":"Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development","volume":"2010","author":"He","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2019.05.084_b0540","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2105-14-S4-S2","article-title":"Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology","volume":"14","author":"Xiang","year":"2013","journal-title":"BMC Bioinf"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.05.084_b0545","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1745-7580-6-S1-S5","article-title":"Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN","volume":"6","author":"He","year":"2010","journal-title":"Immunome Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0550","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2041-1480-2-9","article-title":"Brucellosis ontology (IDOBRU) as an extension of the infectious disease ontology","volume":"2","author":"Lin","year":"2011","journal-title":"J Biomed Semantics"},{"key":"10.1016\/j.vaccine.2019.05.084_b0555","doi-asserted-by":"crossref","first-page":"D923","DOI":"10.1093\/nar\/gkm1039","article-title":"VIOLIN: vaccine investigation and online information network","volume":"36","author":"Xiang","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2019.05.084_b0560","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.vaccine.2015.06.045","article-title":"An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers","volume":"33","author":"Tabynov","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0565","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetmic.2016.11.001","article-title":"First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection","volume":"197","author":"Tabynov","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0570","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.vaccine.2015.12.028","article-title":"Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection","volume":"34","author":"Tabynov","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0575","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7589\/0090-3558-47.3.501","article-title":"DNA vaccination of bison to brucellar antigens elicits elevated antibody and IFN-gamma responses","volume":"47","author":"Clapp","year":"2011","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2019.05.084_b0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186484","article-title":"Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats","volume":"12","author":"Mailybayeva","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2019.05.084_b0585","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2014.02.058","article-title":"Novel influenza virus vectors expressing Brucella L7\/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.084_b0590","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4142\/jvs.2018.19.5.643","article-title":"Vaccination of goats with a combination Salmonella vector expressing four Brucella antigens (BLS, PrpA, Omp19, and SOD) confers protection against Brucella abortus infection","volume":"19","author":"Leya","year":"2018","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2019.05.084_b0595","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/dna.2008.0790","article-title":"A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle","volume":"28","author":"Hu","year":"2009","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0600","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.vetmic.2007.11.015","article-title":"Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle","volume":"129","author":"Saez","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.084_b0605","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1586\/erv.11.110","article-title":"Confronting the barriers to develop novel vaccines against brucellosis","volume":"10","author":"Oliveira","year":"2011","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:25Z","timestamp":1759401145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":121,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0264410X19307315"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The advances in brucellosis vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}